Sval3 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the Sval3 protein, a molecular component thought to play a role in cellular organization or signaling pathways. While the exact function of Sval3 may not yet be fully elucidated, it is likely involved in protein-protein interactions or contributes to the structural integrity of certain cellular processes. Proteins like Sval3 are often integral to maintaining the spatial arrangement of molecules within the cell or influencing how signals are transmitted through cellular networks. Inhibiting Sval3 disrupts its functional role, potentially altering intracellular communication or the maintenance of structural stability, depending on its native role within specific cellular pathways.
The mechanisms of action for Sval3 inhibitors are diverse, with some inhibitors binding directly to the active site of the protein, preventing its interactions with other molecules, while others may induce conformational changes that reduce its efficacy in performing its cellular tasks. These inhibitors can have broad effects on cellular signaling or structural integrity, as Sval3 may act as a scaffold protein or signaling mediator. By blocking its activity, Sval3 inhibitors help scientists better understand the protein's role in various cellular processes, providing insights into how the disruption of specific proteins can cascade into larger systemic effects. Exploring Sval3 inhibition also highlights the complex nature of intracellular dynamics and the finely tuned interactions that govern cellular behavior and function in broader biological systems.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits protein synthesis by preventing the elongation step of translation, potentially leading to decreased expression of seminal vesicle antigen-like 3. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR signaling, which may impact pathways regulating seminal vesicle antigen-like 3 expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib inhibits proteasome activity, potentially leading to the accumulation of proteins involved in regulating seminal vesicle antigen-like 3 expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits topoisomerase I, which may lead to alterations in DNA structure and impact seminal vesicle antigen-like 3 expression. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Nifedipine inhibits L-type calcium channels, potentially disrupting signaling pathways involved in seminal vesicle antigen-like 3 expression. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin inhibits PI3K, a kinase involved in cellular signaling, which may impact pathways regulating seminal vesicle antigen-like 3 expression. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin inhibits protein glycosylation, potentially affecting protein folding and secretion, thus influencing seminal vesicle antigen-like 3 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A inhibits histone deacetylases, potentially altering chromatin structure and influencing seminal vesicle antigen-like 3 expression. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is a calcium ionophore that can modulate signaling pathways, potentially influencing seminal vesicle antigen-like 3 expression. | ||||||
SB 218078 | 135897-06-2 | sc-203692 | 1 mg | $133.00 | 1 | |
SB-218078 inhibits GSK-3β, a kinase involved in cellular signaling, which may impact pathways regulating seminal vesicle antigen-like 3 expression. | ||||||